TissueGen, a developer of cutting-edge absorbable polymer technology for implantable drug delivery, is showing its biodegradable Elute fibre for advanced drug delivery, nerve regeneration, and tissue engineering applications, at the Society for Neuroscience’s annual meeting, Neuroscience 2015, held at McCormick Place Convention Center, Chicago, Illinois, booth 1827, from October 17 to 21, 2015.

TissueGen’s Elute fibre, available in pharmaceutical and growth factor formats, is ideal for advanced drug delivery, nerve regeneration, and tissue engineering applications. Elute fibre directly replaces traditional fibres in medical textiles to potentially improve clinical outcomes by delivering temperature sensitive therapeutics and live biologics directly at the site of implant, according to a press release.

TissueGen Inc. has more than four decades of cumulative experience in extruding biodegradable polymer fibres with broad drug delivery capabilities well-suited for advanced drug delivery, nerve regeneration, and tissue engineering. (GK)